With COVID-19, clean and healthy air is more important than ever! Choose the innovative Calistair Technology now and enjoy the benefits of a personal decontamination system. Calistair Technology has a long history of successful use in many hospitals and has firmly established itself in this environment.
With the Calistair C300 you too can eliminate almost all air contaminants - including COVID-19*. Whether it's a medical practice, legal office, corporate or private premises: The Calistair C300 keeps corona and other viruses out*.
Another advantage, Bacteria, fungi, allergens along with volatile and organic compounds in gaseous form are also effectively eliminated from indoor air. What makes the Calistair C300 so special, It has been demonstrated to eliminate all types of micro-organisms at pre-filtering. Further positive feature is a pleasant smell in the room. Even today, leading hospitals and laboratories rely on Calistair Technology to provide highly efficient solutions for air purification and personal protection. Whether it's a surgery unit, COVID-19 ward, patient room or neonatal care.
In contrast to conventional air purifiers, the underlying technology of the Calistair C300 is based on that of a professional decontamination unit and ensures effective disintegration of the captured contaminant particles within minutes. This is confirmed by tests conducted by a prestigious institute: In fact, the Calistair C300 fully complies with Class 2 of the stringent French standard for clean air in healthcare facilities (NF S90-351) when operating in a 40m³* room.
*The institute that carried out the tests confirmed that the technology invented by Calistair destroys more than 99.4% of human airborne coronavirus of the HCoV-229E type within 10 minutes. The tests used a miniaturised prototype in a microbiological safety container with a volume of 0.54 m3. No other aids like filters were used, instead just the Calistair Technology. The coronavirus HCoV-229E is a coronavirus of the same family as SARS-CoV-2, the virus responsible for the COVID-19 disease.
For more information, contact us at firstname.lastname@example.org